MedTrace Logo

Hair Fall in Patients on Low Dose Methotrexate

NCT02591823 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2016-01-14

No results posted yet for this study

Summary

Low dose methotrexate used in rheumatoid arthritis is considered very safe and has a side effect profile very different from that seen with high dose methotrexate used in oncology. Hair fall has been found to occur in high dose methotrexate but there is no data regarding the same when methotrexate is used in low dose.Thus this observational case control study is being undertaken to determine whether rheumatoid arthritis patients really need to be concerned about hair fall when on low dose methotrexate.

Conditions

Sponsors & Collaborators

  • Columbia Asia

    lead OTHER

Principal Investigators

  • Sharath Kumar, MBBS,MD,DNB · Columbia Asia Hospitals,Bangalore

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-04-30
Completion
2016-05-31

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02591823 on ClinicalTrials.gov